BSR and BHPR guideline for the treatment of systemic sclerosis

Authors: Christopher P. Denton, Michael Hughes, Nataliya Gak, Josephine Vila, Maya H Buch, Kuntal Chakravarty, Kim Fligelstone, Luke Gompels, Bridget Griffiths, Ariane L. Herrick, Jay Pang, Louise Parker, Anthony C. Redmond, Jacob M. van Laar, Louise Warburton, Voon H Ong, on behalf of the BSR and BHPR Standards, Guidelines and Audit Working Group - Lara D. Veeken 2016 cited by 210

SCOPE AND PURPOSE: SSc is a complex, multi-organ disease that requires a comprehensive multidisciplinary guideline. This is a short summary of the guideline, which is available in full as supplementary material at Rheumatology Online. Each recommendation is graded for level of evidence (I-IV) and strength (A-D). ELIGIBILITY AND EXCLUSION CRITERIA: Patients are classified as having SSc based on current classification criteria (ACR/EULAR 2013 [1]). Other scleroderma spectrum diseases are not included in this document.